Back

Impact of triple vasodilator therapy on prognosis stratification of pulmonary arterial hypertension associated with congenital heart disease

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk assessment in pulmonary hypertension: still a hot topic Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Raquel Luna

Hospital Clinic of Barcelona, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Comprehensive risk assessment in patients with pulmonary arterial hypertension referred for lung transplantation: a single-center experience
Doctor S. Ishii (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
REVEAL Score performance in patients with WHO Group 2 pulmonary hypertension
Doctor D. Sharp Dimitri (Cincinnati, US)
Abstract Slides Video
Presentation thumbnail
Analysis of prognostic predictors and differences between subgroups of pulmonary arterial hypertension associated with portal hypertension and HIV infection
Doctor R. Bertozzi (Cesena, IT)
Abstract Slides Video
Presentation thumbnail
Applicability of the 3-Strata ESC/ERS risk model at baseline in pulmonary veno-occlusive disease
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Phenotype and outcome correlates of high dose loop diuretics in type 1 pulmonary hypertension
Doctor D. Barbisan (Treviso, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk assessment in pulmonary hypertension: still a hot topic

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources